Chronic Myeloid Leukemia (CML) is a condition that demands our attention and compassion. This year we’re coming together with the theme Equity in Action: Leaving No CML Patient Behind. Our mission is simple: make sure every CML patient, wherever they are, has equal access to diagnosis, treatment, and support. Let’s take action and ensure no one is left behind.

This year also marks a major milestone: 25 years since the development of Tyrosine Kinase Inhibitors (TKIs).
These life-changing therapies revolutionized CML care and gave thousands of patients a future they never thought possible.

This is your moment to reflect, celebrate, and share. So, we ask you to join us as we unite for #WCMLD25 and tell us: What do 25 years of TKIs mean to you? Let your voice be heard!